Alan H Heaton

Summary

Affiliation: Blue Cross and Blue Shield of Minnesota
Country: USA

Publications

  1. ncbi request reprint The economic effect of hypoglycemia in a health plan
    Alan Heaton
    Pharmacoeconomic and Outcomes Research Department, Prime Therapeutics Inc, Eagan, Minnesota, USA
    Manag Care Interface 16:23-7. 2003
  2. ncbi request reprint The DERP: is it an effective methodology?
    Alan H Heaton
    Blue Cross and Blue Shield of Minnesota, Eagan, Minnesota, USA
    Health Aff (Millwood) 25:W276-8. 2006
  3. ncbi request reprint Rosiglitazone and pioglitazone utilization from January 2007 through May 2008 associated with five risk-warning events
    Catherine I Starner
    Prime Therapeutics LLC, Eagan, Minnesota, USA
    J Manag Care Pharm 14:523-31. 2008
  4. ncbi request reprint Plan designs that encourage the use of generic drugs over brand-name drugs: an analysis of a free generic benefit
    Holly A Rodin
    Blue Cross Blue Shield of Minnesota, 3400 Yankee Dr, R259, Eagan, MN 55122, USA
    Am J Manag Care 15:881-8. 2009
  5. ncbi request reprint Telithromycin: the perils of hasty adoption and persistence of off-label prescribing
    Patrick P Gleason
    Prime Therapeutics LLC, Eagan, MN 55121, USA
    J Manag Care Pharm 13:420-5. 2007
  6. ncbi request reprint Relationship of the magnitude of member cost-share and medication persistence with newly initiated renin angiotensin system blockers
    Dongmu Zhang
    University of Minnesota, Minneapolis, MN, USA
    J Manag Care Pharm 13:664-76. 2007
  7. doi request reprint Clinical and economic outcomes of medication therapy management services: the Minnesota experience
    Brian J Isetts
    College of Pharmacy, University of Minnesota, Minneapolis 55455, USA
    J Am Pharm Assoc (2003) 48:203-11; 3 p following 211. 2008

Collaborators

Detail Information

Publications7

  1. ncbi request reprint The economic effect of hypoglycemia in a health plan
    Alan Heaton
    Pharmacoeconomic and Outcomes Research Department, Prime Therapeutics Inc, Eagan, Minnesota, USA
    Manag Care Interface 16:23-7. 2003
    ..04 per patient per month. Although the financial burden is smaller than that of late complications of diabetes, hypoglycemia associated with insulin therapy is associated with significant costs to the health care system...
  2. ncbi request reprint The DERP: is it an effective methodology?
    Alan H Heaton
    Blue Cross and Blue Shield of Minnesota, Eagan, Minnesota, USA
    Health Aff (Millwood) 25:W276-8. 2006
    ..A perfect process is a long way off. However, continuing to explore the methodologies in place today can lead us to more effective processes and metrics...
  3. ncbi request reprint Rosiglitazone and pioglitazone utilization from January 2007 through May 2008 associated with five risk-warning events
    Catherine I Starner
    Prime Therapeutics LLC, Eagan, Minnesota, USA
    J Manag Care Pharm 14:523-31. 2008
    ....
  4. ncbi request reprint Plan designs that encourage the use of generic drugs over brand-name drugs: an analysis of a free generic benefit
    Holly A Rodin
    Blue Cross Blue Shield of Minnesota, 3400 Yankee Dr, R259, Eagan, MN 55122, USA
    Am J Manag Care 15:881-8. 2009
    ..To evaluate the effect on adherence and medical care expenditures of a pharmacy benefit change that included free generic drugs and higher copayments for brand-name drugs...
  5. ncbi request reprint Telithromycin: the perils of hasty adoption and persistence of off-label prescribing
    Patrick P Gleason
    Prime Therapeutics LLC, Eagan, MN 55121, USA
    J Manag Care Pharm 13:420-5. 2007
    ..On February 12, 2007, the U.S. Food and Drug Administration (FDA) removed the bacterial sinusitis and ABECB indications and strengthened safety warnings for telithromycin...
  6. ncbi request reprint Relationship of the magnitude of member cost-share and medication persistence with newly initiated renin angiotensin system blockers
    Dongmu Zhang
    University of Minnesota, Minneapolis, MN, USA
    J Manag Care Pharm 13:664-76. 2007
    ..Little is known about the relationship between the magnitude of member cost-sharing and antihypertensive persistence among members newly initiating therapy...
  7. doi request reprint Clinical and economic outcomes of medication therapy management services: the Minnesota experience
    Brian J Isetts
    College of Pharmacy, University of Minnesota, Minneapolis 55455, USA
    J Am Pharm Assoc (2003) 48:203-11; 3 p following 211. 2008
    ....